US Department of Health and Human Services, Food and Drug Administration, “Guidance for Industry: Bioanalytical Method Validation,” Rockville, 2001. http://www.fda.gov/CDER/GUIDANCE/4252fnl.htm

has been cited by the following article:

• TITLE: The Use of Dried Blood Spot Samples in Screening Drugs of Abuse

  AUTHORS: Rizwana Quraishi, Raka Jain, Atul Ambekar

  KEYWORDS: Dried Blood Spots; Drugs of Abuse; Screening; Review

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.4 No.2, April 12, 2013

  ABSTRACT: The present article will provide an overview of use of dried blood sampling method for analysis of drug of abuse. Relatively short half life and instability in blood, calls for alternative sampling method for determination of drugs of abuse. Dried blood spot (DBS) method has many advantages over the conventional sampling methods. The available method for DBS sample collection, storage and transport are described here. The techniques involved in and the factors that may influence the accuracy and reproducibility of the DBS methods for determination of drugs of abuse are presented. The DBS sampling has the potential to be a useful technique to detect drugs of abuse. The use of DBS for any drug should be judged against the potential error involved with the method.